Literature DB >> 18167002

Adaptive RT in rectal cancer: superior to 3D-CRT? A simple question, a complex answer.

Karin Haustermans1, Sarah Roels, Jan Verstraete, Tom Depuydt, Pieter Slagmolen.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 18167002     DOI： 10.1007/s00066-007-2009-2

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  6 in total

1.  Postoperative morbidity following chemoradiation for locally advanced low rectal cancer.

Authors:  Ingrid Stelzmueller; Matthias Zitt; Felix Aigner; Reinhold Kafka-Ritsch; Robert Jäger; Alexander De Vries; Peter Lukas; Wolfgang Eisterer; Hugo Bonatti; Dietmar Ofner
Journal:  J Gastrointest Surg       Date:  2008-12-11       Impact factor: 3.452

2.  Can the radiation dose to CT-enlarged but FDG-PET-negative inguinal lymph nodes in anal cancer be reduced?

Authors:  Sabine Kathrin Mai; Grit Welzel; Brigitte Hermann; Frederik Wenz; Uwe Haberkorn; Dietmar Jörg Dinter
Journal:  Strahlenther Onkol       Date:  2009-04-16       Impact factor: 3.621

3.  Impact of (18)F-FDG-PET/CT on staging and irradiation of patients with locally advanced rectal cancer.

Authors:  Brigita Paskeviciute; Tobias Bölling; Markus Brinkmann; Ganna Rudykina; Iris Ernst; Lars Stegger; Otmar Schober; Normann Willich; Matthias Weckesser; Stefan Könemann
Journal:  Strahlenther Onkol       Date:  2009-04-16       Impact factor: 3.621

Review 4.  Molecular targeted treatment and radiation therapy for rectal cancer.

Authors:  Friederike Marquardt; Franz Rödel; Gianni Capalbo; Christian Weiss; Claus Rödel
Journal:  Strahlenther Onkol       Date:  2009-06-09       Impact factor: 3.621

5.  Effect of total mesorectal excision on the outcome of rectal cancer after standardized postoperative radiochemotherapy: do randomized studies translate into clinical routine?

Authors:  Ludwig Keilholz; Mesud Mese; Klaus Henneking; Jochen Willner
Journal:  Strahlenther Onkol       Date:  2009-06-09       Impact factor: 3.621

6.  Gold markers for tumor localization and target volume delineation in radiotherapy for rectal cancer.

Authors:  Hilke Vorwerk; Thorsten Liersch; Hilka Rothe; Michael Ghadimi; Hans Christiansen; Clemens Friedrich Hess; Robert Michael Hermann
Journal:  Strahlenther Onkol       Date:  2009-02-25       Impact factor: 3.621
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.